[American Thoracic Society American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX - ()] D101. CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD - Effects of the Novel Inhaled Phosphodiesterase-4 (PDE4) Inhibitor CHF6001 in Targeting Markers of Inflammation in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
Singh, D., Govoni, M., Beeh, K.M., Colgan, B., Kornmann, O., Leaker, B., Watz, H., Lucci, G., Geraci, S., Calabro Rocco, E., Emirova, A., Nandeuil, M.A.DOI:
10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7095
File:
PDF, 107 KB